Supreme Court Addresses Product of Nature Doctrine Relating to Gene Patents The Supreme Court today handed down its decision in Association for Molecular Pathology v. Myriad Genetics, Inc. The Court held that isolated DNA is a product of nature and not patent eligible merely because it has been isolated, but that complementary DNA (cDNA) is patent eligible because it is not naturally occurring. The Court limited […] Continue Reading →